Pacing Dependence at 1 Year Follow-up in Patients Implanted With a Pacemaker After TAVR: a Multicenter Observational Study.

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

Pace maker implantation after the procedure of TAVR can be estimated at 15% of patients. However, some studies have shown that the conduction disturbances after TAVR could resolve over time, and that roughly between one- and two-thirds of patients who required a permanent pace maker implantation post TAVR were not found to be dependent at subsequent follow-up. This study aims to evaluate a cohort of patients permanently implanted with a pacemaker post-TAVR for high-grade conductive disorders and to describe the prevalence of effective pacemaker stimulation at 1 year follow-up. Secondary objectives include the evaluation of the prevalence of effective stimulation 3 months after implantation of the pace maker , description of the types of conductive disorders associated with atrial and/or ventricular stimulation, description of the initial indication for pacemaker implantation, description of the characteristics of the population with or without stimulation dependency. The objective is to better rationalize indication of permanent stimulation after TAVI

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• all patients who need a permanent pacemaker implantation after TAVR

Locations
Other Locations
France
University Hospital of Montpellier
RECRUITING
Montpellier
Contact Information
Primary
Florence Leclercq, PUPH
f-leclercq@chu-montpellier.fr
0467336189
Time Frame
Start Date: 2024-11-13
Estimated Completion Date: 2027-10-13
Participants
Target number of participants: 90
Treatments
Patients who need permanent pace maker implantation after TAVR
patients with high degree conductive disorders after TAVR who required pacemaker implantation before discharge the study will evaluated pacing dependency at one year (main objective) and the profile of patients with pacing dependency (type of initial conductive disorder, clinical characteristics)
Related Therapeutic Areas
Sponsors
Collaborators: Biotronik France
Leads: University Hospital, Montpellier

This content was sourced from clinicaltrials.gov